Skip to main content
Year archive

HLB Life Science CO.,LTD. — 2026 filings

All 20 regulatory filings released by HLB Life Science CO.,LTD. (067630) in 2026, sourced directly from the official regulator.

20 Filings
2026 Period
2026 filings (20)
Filing Released Lang
교환가액의조정 (제16회차)
Capital/Financing Update
2026-05-21 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Q1 2026
2026-05-15 Korean
주요사항보고서(영업정지)
Regulatory Filings
2026-05-15 Korean
주권매매거래정지 (중요한 영업정지)
Regulatory Filings
2026-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-31 Korean
대표이사변경
Board/Management Information
2026-03-31 Korean
기업설명회(IR)개최
Investor Presentation
2026-03-26 Korean
기업설명회(IR)개최
Investor Presentation
2026-03-26 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-23 Korean
사업보고서 (2025.12)
Audit Report / Information FY 2025
2026-03-23 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2026-03-11 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2026-03-11 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2026-03-11 Korean
전환사채(해외전환사채포함)발행후만기전사채취득 (제13회차)
Capital/Financing Update
2026-03-03 Korean
전환사채(해외전환사채포함)발행후만기전사채취득 (제13회차)
Capital/Financing Update
2026-02-25 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2025
2026-02-20 Korean
증권발행결과(자율공시) (제16회차 EB)
Capital/Financing Update
2026-02-20 Korean
전환사채(해외전환사채포함)발행후만기전사채취득 (제13회차)
Capital/Financing Update
2026-02-19 Korean
타법인주식및출자증권처분결정
Share Issue/Capital Change
2026-02-12 Korean
주요사항보고서(교환사채권발행결정)
Capital/Financing Update
2026-01-22 Korean